Salacca zalacca peel modulates uricemia and IL-6 in rats
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2467
DOI: 10.56499/jppres_14.2.2467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Danis Pertiwi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Hyperuricemia promotes oxidative stress and inflammation. Ethanolic salak (Salacca zalacca) peel extract (ESP) contains flavonoids with antioxidant potential.
Aims
To evaluate the effects of ESP on serum uric acid (UA), interleukin-6 (IL-6), and glutathione peroxidase (GPx) protein levels in hyperuricemic rats.
Methods
Male Wistar rats (n=30) were allocated to five groups (normal control; hyperuricemic control; allopurinol 9 mg/kg; ESP 210 or 420 mg/kg). Hyperuricemia was induced using a high-purine chicken-liver regimen. UA was measured pre- and post-treatment by a uricase-peroxidase colorimetric assay (520 nm). IL-6 and GPx protein levels were determined by enzyme-linked immunosorbent assay (ELISA) (450 nm).
Results
ESP 420 mg/kg reduced UA to 2.22 ± 0.06 mg/dL (Δ5.78 ± 0.10), lowered IL-6 to 32.96 ± 1.51 pg/mL, and increased GPx protein levels to 51.19 ± 0.72 pg/mL. Group differences were significant (ANOVA, p
Zitieren
APA
Pertiwi, D., Puspaningrum, D. K., & Mardhiani, F. A. (2026). Salacca zalacca peel modulates uricemia and IL-6 in rats. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2467. https://doi.org/10.56499/jppres_14.2.2467
Vancouver
Pertiwi D, Puspaningrum DK, Mardhiani FA. Salacca zalacca peel modulates uricemia and IL-6 in rats. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2467. doi:10.56499/jppres_14.2.2467
BibTeX
@article{Pertiwi2026,
author = {Pertiwi, Danis and Puspaningrum, Dimar K. and Mardhiani, Fanny A.},
title = {Salacca zalacca peel modulates uricemia and IL-6 in rats},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2467},
doi = {10.56499/jppres_14.2.2467}
}
EUVIMED